Summary
HELSINKI, Finland, July 25 /U.S. Newswire/ -- A study released today could reveal the key to treating nearly 140 million people worldwide who suffer from spinal cord injuries, Alzheimer's disease, ALS and other devastating neurological diseases.
The study, published in the online version of the Journal of Neuroscience Research, shows how a protein called KDI tri-peptide (KDI) can block the harmful effects of a substance called glutamate that is present in all degenerative brain diseases and spinal cord injuries, causing permanent cell death and preventing the repair of damaged nerve connections. Glutamate is produced as part of the body's natural reaction to central nervous system damage.See the full content of this document
Extract
New Study Reveals Potential for Radical New Treatment of Paralysisand Brain Disease
In the new study, researchers at the Brain Laboratory at the University of Helsinki -- http://www.brainlab.fi -- and at the Johnnie B. Byrd Sr., Alzheimer's Center & Research Institute in Tampa, Fla., show KDI to be a potent and wide-ranging b...
See the full content of this document
Sponsored links
